EP3129401 - SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.04.2020 Database last updated on 15.08.2024 | |
Former | The patent has been granted Status updated on 10.05.2019 | ||
Former | Grant of patent is intended Status updated on 04.05.2019 | ||
Former | Examination is in progress Status updated on 09.04.2019 | ||
Former | Grant of patent is intended Status updated on 06.12.2018 | ||
Former | Examination is in progress Status updated on 15.09.2017 | ||
Former | Request for examination was made Status updated on 13.01.2017 | ||
Former | The international publication has been made Status updated on 09.11.2016 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US | [2017/07] | Inventor(s) | 01 /
MITCHELL, Tracy, S. 100 Beaver Street Waltham, MA 02453 / US | 02 /
GOSSELIN, Michael, L. 100 Beaver Street Waltham, MA 02453 / US | 03 /
LIPOVSEK, Dasa 100 Beaver Street Waltham, MA 02453 / US | 04 /
PARKER, Rex 147 Church Road Titusville, NJ 08560 / US | 05 /
CAMPHAUSEN, Ray 100 Beaver Street Waltham, MA 02453 / US | 06 /
DAVIS, Jonathan 100 Beaver Street Waltham, MA 02453 / US | 07 /
FABRIZIO, David 79 Lincoln Avenue South Hamilton, MA 01982 / US | [2017/07] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
Former [2017/07] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 15714135.9 | 19.03.2015 | [2017/07] | WO2015US21535 | Priority number, date | US201461968181P | 20.03.2014 Original published format: US 201461968181 P | [2017/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015143199 | Date: | 24.09.2015 | Language: | EN | [2015/38] | Type: | A1 Application with search report | No.: | EP3129401 | Date: | 15.02.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.09.2015 takes the place of the publication of the European patent application. | [2017/07] | Type: | B1 Patent specification | No.: | EP3129401 | Date: | 12.06.2019 | Language: | EN | [2019/24] | Search report(s) | International search report - published on: | EP | 24.09.2015 | Classification | IPC: | C07K14/765, A61K38/39, A61K47/50, C07K14/78, C12N15/62 | [2017/07] | CPC: |
C07K14/78 (EP,CN,EA,IL,KR,US);
A61K38/39 (EA,IL);
A61K38/00 (EP,CN,EA,IL,KR,US);
A61K47/64 (EP,EA,IL,KR,US);
C07K14/765 (IL);
C12N15/62 (EA,IL);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/07] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | SERUMALBUMINBINDENDE FIBRONECTIN-TYP-III-DOMÄNEN | [2017/07] | English: | SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS | [2017/07] | French: | DOMAINES DE FIBRONECTINE DE TYPE III SE LIANT À L'ALBUMINE SÉRIQUE | [2017/07] | Entry into regional phase | 07.10.2016 | National basic fee paid | 07.10.2016 | Designation fee(s) paid | 07.10.2016 | Examination fee paid | Examination procedure | 07.10.2016 | Examination requested [2017/07] | 07.10.2016 | Date on which the examining division has become responsible | 04.05.2017 | Amendment by applicant (claims and/or description) | 13.09.2017 | Despatch of a communication from the examining division (Time limit: M04) | 22.01.2018 | Reply to a communication from the examining division | 16.03.2018 | Despatch of a communication from the examining division (Time limit: M04) | 25.07.2018 | Reply to a communication from the examining division | 07.12.2018 | Communication of intention to grant the patent | 04.04.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 04.04.2019 | Fee for grant paid | 04.04.2019 | Fee for publishing/printing paid | 03.05.2019 | Information about intention to grant a patent | 03.05.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19170042.6 / EP3572424 | Opposition(s) | 13.03.2020 | No opposition filed within time limit [2020/21] | Fees paid | Renewal fee | 10.03.2017 | Renewal fee patent year 03 | 13.03.2018 | Renewal fee patent year 04 | 13.03.2019 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 19.03.2015 | AL | 12.06.2019 | AT | 12.06.2019 | CY | 12.06.2019 | CZ | 12.06.2019 | DK | 12.06.2019 | EE | 12.06.2019 | FI | 12.06.2019 | HR | 12.06.2019 | LT | 12.06.2019 | LV | 12.06.2019 | MC | 12.06.2019 | MK | 12.06.2019 | MT | 12.06.2019 | NL | 12.06.2019 | PL | 12.06.2019 | RO | 12.06.2019 | RS | 12.06.2019 | SE | 12.06.2019 | SI | 12.06.2019 | SK | 12.06.2019 | SM | 12.06.2019 | TR | 12.06.2019 | BG | 12.09.2019 | NO | 12.09.2019 | GR | 13.09.2019 | IS | 12.10.2019 | PT | 14.10.2019 | [2022/32] |
Former [2022/28] | HU | 19.03.2015 | |
AL | 12.06.2019 | ||
AT | 12.06.2019 | ||
CY | 12.06.2019 | ||
CZ | 12.06.2019 | ||
DK | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
MC | 12.06.2019 | ||
MT | 12.06.2019 | ||
NL | 12.06.2019 | ||
PL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SI | 12.06.2019 | ||
SK | 12.06.2019 | ||
SM | 12.06.2019 | ||
TR | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
IS | 12.10.2019 | ||
PT | 14.10.2019 | ||
Former [2020/50] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
DK | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
MC | 12.06.2019 | ||
NL | 12.06.2019 | ||
PL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SI | 12.06.2019 | ||
SK | 12.06.2019 | ||
SM | 12.06.2019 | ||
TR | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
IS | 12.10.2019 | ||
PT | 14.10.2019 | ||
Former [2020/36] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
DK | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
PL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SI | 12.06.2019 | ||
SK | 12.06.2019 | ||
SM | 12.06.2019 | ||
TR | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
IS | 12.10.2019 | ||
PT | 14.10.2019 | ||
Former [2020/24] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
DK | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
PL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SI | 12.06.2019 | ||
SK | 12.06.2019 | ||
SM | 12.06.2019 | ||
TR | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
PT | 14.10.2019 | ||
IS | 24.02.2020 | ||
Former [2020/22] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
DK | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SK | 12.06.2019 | ||
SM | 12.06.2019 | ||
TR | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
IS | 12.10.2019 | ||
PT | 14.10.2019 | ||
Former [2020/17] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SK | 12.06.2019 | ||
SM | 12.06.2019 | ||
TR | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
IS | 12.10.2019 | ||
PT | 14.10.2019 | ||
Former [2020/14] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SK | 12.06.2019 | ||
SM | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
IS | 12.10.2019 | ||
PT | 14.10.2019 | ||
Former [2020/12] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SK | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
IS | 12.10.2019 | ||
PT | 14.10.2019 | ||
Former [2020/11] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
EE | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
SK | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
PT | 14.10.2019 | ||
Former [2020/10] | AL | 12.06.2019 | |
AT | 12.06.2019 | ||
CZ | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
RO | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
PT | 14.10.2019 | ||
Former [2020/09] | AL | 12.06.2019 | |
CZ | 12.06.2019 | ||
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
Former [2020/07] | AL | 12.06.2019 | |
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
NL | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
Former [2019/51] | AL | 12.06.2019 | |
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
BG | 12.09.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
Former [2019/50] | AL | 12.06.2019 | |
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
LV | 12.06.2019 | ||
RS | 12.06.2019 | ||
SE | 12.06.2019 | ||
NO | 12.09.2019 | ||
GR | 13.09.2019 | ||
Former [2019/49] | AL | 12.06.2019 | |
FI | 12.06.2019 | ||
HR | 12.06.2019 | ||
LT | 12.06.2019 | ||
SE | 12.06.2019 | ||
NO | 12.09.2019 | ||
Former [2019/48] | FI | 12.06.2019 | |
LT | 12.06.2019 | ||
SE | 12.06.2019 | ||
NO | 12.09.2019 | ||
Former [2019/47] | FI | 12.06.2019 | |
LT | 12.06.2019 | ||
NO | 12.09.2019 | Cited in | International search | [A]WO2008096158 (DOMANTIS LTD [GB], et al) [A] 1-20 * the whole document *; | [A]WO2009083804 (NOVARTIS AG [CH], et al) [A] 1-20 * the whole document *; | [XI]WO2009133208 (NOVARTIS AG [CH], et al) [X] 1-3,7-11,15,16,18-20 * the whole document * * pages 12,14,19; figures 7,9,13,14; example -; claim -; sequences 1-3 * [I] 1-20; | [XI]WO2011103105 (BRISTOL MYERS SQUIBB CO [US], et al) [X] 1-4,9-11,15,16,18-20 * the whole document * * paragraphs [[20]] - [[26]] - [[115]] - [[123]] - [[197]]; example -; claim -; sequence - * [I] 1-20; | [XI]WO2011130354 (BRISTOL MYERS SQUIBB CO [US], et al) [X] 1-4,9-13,15-20 * paragraphs [0002] , [00 7] - [0014] - [0 37] - [42 67] - [0074] - [0 83] - [0117] - [ 170] - [0191]; example -; sequence 327 * * paragraphs [[0030]] , [[0031]] , [ [0038]] - [[0040]] - [[0176]] , [ [0241]]; example 5F; claim - * * the whole document * [I] 1-20; | [XI]WO2011140086 (BRISTOL MYERS SQUIBB CO [US], et al) [X] 1-4,7,9-11,15,16,18-20 * the whole document * * claim 46 * * example -; claim - * * page 79; sequence 1 * [I] 1-20; | [XP]WO2014165093 (BRISTOL MYERS SQUIBB CO [US]) [XP] 1-4,9-12,15,16,18-20 * the whole document * * examples 1-3; claim -; sequence 154 *; | [XI] - PETER-CHRISTIAN KLÖHN ET AL, "IBC's 23nd Annual Antibody Engineering, 10th Annual Antibody Therapeutics International Conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA", MABS, (20130301), vol. 5, no. 2, doi:10.4161/mabs.23655, ISSN 1942-0862, pages 178 - 201, XP055137110 [X] 1-4,9-11,15,16,18-20 * page 194, column R * [I] 1-20 DOI: http://dx.doi.org/10.4161/mabs.23655 | [A] - LIPOVSEK D, "Adnectins: engineered target-binding protein therapeutics", PROTEIN ENGINEERING, DESIGN AND SELECTION, OXFORD JOURNAL, LONDON, GB, vol. 24, no. 1-2, Sp. Iss. SI, doi:DOI:10.1093/PROTEIN/GZQ097, ISSN 1741-0126, (20101110), pages 3 - 9, XP008153459 [A] 1-20 * the whole document * DOI: http://dx.doi.org/ | [A] - SLEEP DARRELL ET AL, "Albumin as a versatile platform for drug half-life extension", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - GENERAL SUBJECTS, (20130429), vol. 1830, no. 12, doi:10.1016/J.BBAGEN.2013.04.023, ISSN 0304-4165, pages 5526 - 5534, XP028740219 [A] 1-20 * the whole document * DOI: http://dx.doi.org/10.1016/j.bbagen.2013.04.023 |